Which is better, HRMY or ONC?

On the Buffett-Fit framework, BeOne Medicines Ltd. (ONC) currently grades higher than HRMY — 62/100 (D grade) vs 67/100 (B). That said, "better" depends on which framework you trust — HRMY wins on Warren Buffett, Charlie Munger, and Terry Smith; ONC wins on Benjamin Graham, Philip Fisher, Peter Lynch, and Joel Greenblatt. The full pillar breakdown is on this page.

Should I buy HRMY or ONC?

This page is an educational comparison, not investment advice. Both HRMY and ONC are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is HRMY better than ONC for value investing?

On the Buffett-style value-investing framework, ONC currently grades higher — 67/100 vs 62/100, a 5-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between HRMY and ONC on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). HRMY currently scores 67/100 (B grade); ONC scores 62/100 (D grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, HRMY or ONC?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. HRMY and ONC are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, HRMY or ONC?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are HRMY and ONC both Healthcare stocks?

Yes — both Harmony Biosciences Holdings, Inc. (HRMY) and BeOne Medicines Ltd. (ONC) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this HRMY vs ONC comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Harmony Biosciences Holdings

BeOne Medicines

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

HRMY

Market cap

$1.75B

Sector

Healthcare

ONC

BeOne Medicines

Market cap

$33.15B

Sector

Healthcare

Overall winner

BeOne Medicines ONC

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	HRMY	ONC	Winner
Warren Buffett	67B	62D	HRMY
Benjamin Graham	60C	75D	ONC
Philip Fisher

Side-by-side metrics

Metric	HRMY	ONC
Market cap	$1.75B	$33.15B
P/E (TTM)	11.8x	107.5x
EV/EBIT	6.4x	28.9x
ROIC (TTM)	12.5%	7.73%
Gross margin	76.55%	87.17%
Net margin	16.2%	8.93%
Revenue CAGR 5y	29.85%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

HRMY leads on

P/E (TTM)11.8xvs 107.5x+89%
EV/EBIT6.4xvs 28.9x+78%
Debt / Equity0.2xvs 0.4x+47%
Net margin16.2%vs 8.93%

More like HRMY

HRMY vs HALO HRMY vs LMAT HRMY vs RMD HRMY vs LLY HRMY vs UTHR HRMY vs HAE

More like ONC

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.